Los Angeles Capital Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Buy |
+15,027
| New | +$334K | ﹤0.01% | 1009 |
|
|
2022
Q3 | – | Sell |
-20,783
| Closed | -$422K | – | 1218 |
|
|
2022
Q2 | $422K | Sell |
20,783
-84,828
| -80% | -$1.72M | ﹤0.01% | 1027 |
|
|
2022
Q1 | $2.61M | Sell |
105,611
-16,285
| -13% | -$403K | 0.01% | 472 |
|
|
2021
Q4 | $4.24M | Sell |
121,896
-8,664
| -7% | -$301K | 0.02% | 374 |
|
|
2021
Q3 | $3.54M | Buy |
130,560
+4,355
| +3% | +$118K | 0.02% | 400 |
|
|
2021
Q2 | $3.27M | Buy |
126,205
+50,175
| +66% | +$1.3M | 0.01% | 466 |
|
|
2021
Q1 | $1.64M | Buy |
76,030
+65,660
| +633% | +$1.41M | 0.01% | 685 |
|
|
2020
Q4 | $223K | Sell |
10,370
-11,650
| -53% | -$251K | ﹤0.01% | 1451 |
|
|
2020
Q3 | $325K | Buy |
22,020
+2,300
| +12% | +$33.9K | ﹤0.01% | 1243 |
|
|
2020
Q2 | $441K | Buy |
19,720
+8,170
| +71% | +$183K | ﹤0.01% | 1160 |
|
|
2020
Q1 | $163K | Buy |
+11,550
| New | +$163K | ﹤0.01% | 1225 |
|
|
2019
Q4 | – | Sell |
-12,470
| Closed | -$436K | – | 1264 |
|
|
2019
Q3 | $436K | Hold |
12,470
| – | – | ﹤0.01% | 1023 |
|
|
2019
Q2 | $704K | Buy |
12,470
+1,635
| +15% | +$92.3K | ﹤0.01% | 951 |
|
|
2019
Q1 | $791K | Buy |
10,835
+860
| +9% | +$62.8K | ﹤0.01% | 936 |
|
|
2018
Q4 | $636K | Sell |
9,975
-1,985
| -17% | -$127K | ﹤0.01% | 890 |
|
|
2018
Q3 | $1.19M | Sell |
11,960
-11,330
| -49% | -$1.13M | 0.01% | 808 |
|
|
2018
Q2 | $1.66M | Buy |
+23,290
| New | +$1.66M | 0.01% | 747 |
|